NCT02324335 2019-01-16BrilacidinInnovation Pharmaceuticals, Inc.Phase 2 Completed61 enrolled 12 charts
NCT00101582 2016-09-27Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck CancerSwedish Orphan BiovitrumPhase 3 Completed188 enrolled 19 charts
NCT00956254 2013-09-05Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral MucositisINSYS Therapeutics IncPhase 3 Completed18 enrolled 6 charts